Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse

IntroductionTo sustain the achievement of kala-azar elimination program (KEP), early detection and treatment of the visceral leishmaniasis (VL) cases and associated modalities such as treatment failure (TF), relapse VL (RVL), and Post-kala-azar dermal leishmaniasis (PKDL) is the cornerstone. A predi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dinesh Mondal, Prakash Ghosh, Rajashree Chowdhury, Christine Halleux, Jose A. Ruiz-Postigo, Abdul Alim, Faria Hossain, Md Anik Ashfaq Khan, Rupen Nath, Malcolm S. Duthie, Axel Kroeger, Greg Matlashewski, Daniel Argaw, Piero Olliaro
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019-10-01
Colecção:Frontiers in Microbiology
Assuntos:
visceral leishmaniasis (VL)
treatment failure (TF)
relapse VL (RVL)
Post-kala-azar dermal leishmaniasis (PKDL)
rK39 antibody
ELISA
Acesso em linha:https://www.frontiersin.org/article/10.3389/fmicb.2019.02268/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados